Cargando…
Somatic activating mutations in MAP2K1 cause melorheostosis
Melorheostosis is a sporadic disease of uncertain etiology characterized by asymmetric bone overgrowth and functional impairment. Using whole exome sequencing, we identify somatic mosaic MAP2K1 mutations in affected, but not unaffected, bone of eight unrelated patients with melorheostosis. The activ...
Autores principales: | Kang, Heeseog, Jha, Smita, Deng, Zuoming, Fratzl-Zelman, Nadja, Cabral, Wayne A., Ivovic, Aleksandra, Meylan, Françoise, Hanson, Eric P., Lange, Eileen, Katz, James, Roschger, Paul, Klaushofer, Klaus, Cowen, Edward W., Siegel, Richard M., Marini, Joan C., Bhattacharyya, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895796/ https://www.ncbi.nlm.nih.gov/pubmed/29643386 http://dx.doi.org/10.1038/s41467-018-03720-z |
Ejemplares similares
-
Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway
por: Kang, Heeseog, et al.
Publicado: (2020) -
Clinical Evaluation of Melorheostosis in the Context of a Natural History Clinical Study
por: Jha, Smita, et al.
Publicado: (2019) -
Cross‐Sectional Imaging Useful in Melorheostosis
por: Hurley‐Novatny, Amelia, et al.
Publicado: (2021) -
Combination of Nanoindentation and Quantitative Backscattered Electron Imaging Revealed Altered Bone Material Properties Associated with Femoral Neck Fragility
por: Fratzl-Zelman, N., et al.
Publicado: (2009) -
Hide and seek: Somatic SMAD3 mutations in melorheostosis
por: Velchev, Joe Davis, et al.
Publicado: (2020)